These projects were made possible from Cure Alzheimer's Fund support.
| Project Description | Researchers | Funding |
|---|---|---|
| Molecular Signatures of APOE-Mediated Blood-Brain Barrier Dysfunction Causing Neuronal and Synaptic Dysfunction |
2019-2020 $595,000 |
|
| PICALM Gene Therapy and Drug Screening for Amyloid Beta Clearance (Year 3) |
2018 $300,000 |
|
| The Role of PICALM Mutations in Alzheimer’s Disease |
2015 to 2017 $500,000 |
|
| PICALM Gene Therapy and Drug Screening for Abeta Clearance |
2015 to 2016 $600,170 |
|
| The role of PICALM in vascular clearance of amyloid-B and neuronal injury |
2014 $250,000 |
|
| The role of PICALM in vascular clearance of amyloid-β |
2012 $100,000 |
